Novartis Revenue and Competitors
Estimated Revenue & Valuation
- Novartis's estimated annual revenue is currently $16.1M per year.
- Novartis's estimated revenue per employee is $201,000
Employee Data
- Novartis has 80 Employees.
- Novartis grew their employee count by 1% last year.
Novartis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Novartis?
Novartis Global Health focuses our expertise on delivering life-enhancing medicines and improving access to healthcare for underserved populations. We target disease areas where we can make the most difference. Social business at the heart of all the work we do. See our community guidelines: https://bit.ly/35ExptC
keywords:N/A
N/A
Total Funding
80
Number of Employees
$16.1M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Novartis News
Novartis AG (NVS) stock has risen 1.77% over the last 12 months, and the average rating from Wall Street analysts is a Buy.
Former Novartis exec helms newly launched satellite bio. Published: Apr 20, 2022. By Hayley Shasteen. BioSpace. Satellite Bio launched Wednesday with $110...
Novartis is undertaking a huge restructuring to simplify its organization, and some of its employees will feel the pain.
Other Companies in Basel
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $17.8M | 81 | 47% | N/A |
#2 | $21.9M | 81 | 59% | N/A |
#3 | N/A | 81 | 13% | N/A |
#4 | $18.4M | 81 | 21% | N/A |
#5 | N/A | 82 | 0% | N/A |